Treatment Modalities and Antimicrobial Stewardship Initiatives in the Management of Intra-Abdominal Infections.

Antibiotics (Basel). 2016 Feb 15;5(1).

Hoffmann C1,2, Zak M3, Avery L4,5, Brown J6,7,8.

Author information

1Wegmans School of Pharmacy, St. John Fisher College, Rochester, NY 14618, USA. choffmann@sjfc.edu.

2Department of Pharmacy, University of Rochester Medical Center, Rochester, NY 14642, USA. choffmann@sjfc.edu.

3Wegmans School of Pharmacy, St. John Fisher College, Rochester, NY 14618, USA. mzak@sjfc.edu.

4Wegmans School of Pharmacy, St. John Fisher College, Rochester, NY 14618, USA. lavery@sjfc.edu.

5St. Joseph’s Hospital Health Center, Syracuse, NY 13203, USA. lavery@sjfc.edu.

6Wegmans School of Pharmacy, St. John Fisher College, Rochester, NY 14618, USA. jbrown@sjfc.edu.

7Department of Pharmacy, University of Rochester Medical Center, Rochester, NY 14642, USA. jbrown@sjfc.edu.

8Department of Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA. jbrown@sjfc.edu.

Abstract

Antimicrobial stewardship programs (ASPs) focus on improving the utilization of broad spectrum antibiotics to decrease the incidence of multidrug-resistant Gram positive and Gram negative pathogens.

Hospital admission for both medical and surgical intra-abdominal infections (IAIs) commonly results in the empiric use of broad spectrum antibiotics such as fluoroquinolones, beta-lactam beta-lactamase inhibitors, and carbapenems that can select for resistant organisms.

This review will discuss the management of uncomplicated and complicated IAIs as well as highlight stewardship initiatives focusing on the proper use of broad spectrum antibiotics

abstract

http://www.mdpi.com/2079-6382/5/1/11

PDF (CLIC in DOWNLOAD PDF)